Skip to content
ppharmaranks
Menu

Best treatments for glioblastoma

9 products may treat glioblastoma, spanning FDA drug classes such as vascular endothelial growth factor inhibitor, alkylating drug. The current highest-rated option is mvasi. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 9 drugs we list for glioblastoma, 1 is available as lower-cost generics, spanning classes such as vascular endothelial growth factor inhibitor, alkylating drug. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for glioblastoma — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Top-rated picks for glioblastoma: 1. Mvasi · 2. Alymsys · 3. Avastin

Top-rated treatments for glioblastoma, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100View →
270/100View →
370/100View →
470/100View →
5Not yet ratedView →
6Not yet ratedView →
7Not yet ratedView →
8Not yet rated$149View →
9Not yet ratedView →

Narrow by drug class

Explore the class hubs: alkylating drug

Full ranking · 9 treatments

mvasi

PrescriptionFDA-sourced

72/100

Mvasi (Bevacizumab-Awwb) is a medication used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.

(6 data points)
carcinoma, non-small-cell lunguterine cervical neoplasmsfallopian tube neoplasms

Price varies

View details →

alymsys

PrescriptionFDA-sourced

70/100

Alymsys (Bevacizumab-Maly) is a medication used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.

(11 data points)
carcinoma, non-small-cell lunguterine cervical neoplasmsfallopian tube neoplasms

Price varies

View details →
#1 of 3 in Vascular Endothelial Growth Factor Inhibitor

avastin

PrescriptionFDA-sourced

70/100

Avastin (Bevacizumab) is a vascular endothelial growth factor inhibitor used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.

(5 data points)
vascular endothelial growth factor inhibitorcarcinoma, non-small-cell lunguterine cervical neoplasms

Price varies

View details →
#2 of 11 in Alkylating Drug

gliadel

PrescriptionFDA-sourced

70/100

Gliadel (Carmustine) is an alkylating drug used to treat Brain Neoplasms, Carcinoma, Colonic Neoplasms, Ependymoma.

(3 data points)
alkylating drugbrain neoplasmscarcinoma

Price varies

View details →

avzivi

PrescriptionFDA-sourced

New

Avzivi (Bevacizumab-Tnjn) is a medication used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.

carcinoma, non-small-cell lunguterine cervical neoplasmsfallopian tube neoplasms

Price varies

View details →

bicnu

Boxed warning

PrescriptionFDA-sourced

New

Bicnu (Carmustine) is an alkylating drug used to treat Brain Neoplasms, Carcinoma, Colonic Neoplasms, Ependymoma.

alkylating drugbrain neoplasmscarcinoma

Price varies

View details →

Frequently asked

What treats glioblastoma?
Our catalog lists 9 products that may treat glioblastoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is mvasi.
What is the best-rated treatment for glioblastoma?
By our independent recall-safety rating — not an efficacy measure — mvasi ranks highest among the products we list for glioblastoma. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat glioblastoma?
Treatments for glioblastoma span FDA drug classes including vascular endothelial growth factor inhibitor, alkylating drug. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.